125 related articles for article (PubMed ID: 27918250)
1. Evaluation of Immunostimulatory Effects of N-(2-Hydroxy) Propyl-3-Trimethylammonium Chitosan Chloride for Improving Live Attenuated Hepatitis A Virus Vaccine Efficacy.
Tao W; Fu T; He Z; Hu R; Jia L; Hong Y
Viral Immunol; 2017 Mar; 30(2):120-126. PubMed ID: 27918250
[TBL] [Abstract][Full Text] [Related]
2. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
[TBL] [Abstract][Full Text] [Related]
3. Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
Chen Y; Zhou CL; Zhang XJ; Hao ZY; Zhang YH; Wang SM; Ma JC; Zhao G; Qiu C; Zhao YL; Wang B; Wang XY
Vaccine; 2018 Jan; 36(1):114-121. PubMed ID: 29183734
[TBL] [Abstract][Full Text] [Related]
4. Rectal immunization of mice with hepatitis A vaccine induces stronger systemic and local immune responses than parenteral immunization.
Mitchell LA; Galun E
Vaccine; 2003 Mar; 21(13-14):1527-38. PubMed ID: 12615450
[TBL] [Abstract][Full Text] [Related]
5. [Horizontal transmission of live attenuated hepatitis A vaccine virus].
Huang X; Cao Y; Tan S
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):465-7. PubMed ID: 11798919
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.
Lee EY; Kim JY; Lee DK; Yoon IS; Ko HL; Chung JW; Chang J; Nam JH
Microbiol Immunol; 2016 Dec; 60(12):846-853. PubMed ID: 28004418
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
[TBL] [Abstract][Full Text] [Related]
10. Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.
Weinberg A; Huang S; Fenton T; Patterson-Bartlett J; Gona P; Read JS; Dankner WM; Nachman S;
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):17-24. PubMed ID: 19617848
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes.
Cai MS; Deng SX; Li ML
Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858
[TBL] [Abstract][Full Text] [Related]
12. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.
Gao Y; Su Q; Yi Y; Jia Z; Wang H; Lu X; Qiu F; Bi S
PLoS One; 2015; 10(4):e0123400. PubMed ID: 25875115
[TBL] [Abstract][Full Text] [Related]
13. Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine.
Zhang Z; Zhu X; Hu Y; Liang M; Sun J; Song Y; Yang Q; Ji H; Zeng G; Song L; Chen J
Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28319454
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid.
Mitchell LA; Joseph A; Kedar E; Barenholz Y; Galun E
Vaccine; 2006 Jun; 24(25):5300-10. PubMed ID: 16714070
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated hepatitis A vaccines developed in China.
Xu ZY; Wang XY
Hum Vaccin Immunother; 2014; 10(3):659-66. PubMed ID: 24280971
[TBL] [Abstract][Full Text] [Related]
17. Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus.
de Paula VS; da Silva Ados S; de Vasconcelos GA; Iff ET; Silva ME; Kappel LA; Cruz PB; Pinto MA
J Virol Methods; 2011 Jan; 171(1):102-6. PubMed ID: 20971134
[TBL] [Abstract][Full Text] [Related]
18. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
Dong C; Dai X; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
[TBL] [Abstract][Full Text] [Related]
19. Adherence to hepatitis A virus vaccination in HIV-infected men who have sex with men.
Kourkounti S; Paparizos V; Leuow K; Paparizou E; Antoniou C
Int J STD AIDS; 2015 Oct; 26(12):852-6. PubMed ID: 25411352
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
